Stryker Enters China Race With Trauson Bid
Executive Summary
The race to acquire a local foothold in China’s medical device industry is on. Stryker's bid to pay $764 million for Trauson Holdings would take out China’s second sizable domestic supplier of orthopedic implants.
You may also be interested in...
ArthroCare Bid Signals Ortho Consolidation
If completed, Smith & Nephew’s acquisition of ArthroCare would help it diversify into the ENT market, but the deal may not get done as analysts speculate that competitors Stryker and J&J could step in with counteroffers. The interest surrounding ArthroCare emphasizes the pressures being put on large joint makers to find new ways of making money in orthopedics.
ArthroCare Bid Signals Ortho Consolidation
If completed, Smith & Nephew’s acquisition of ArthroCare would help it diversify into the ENT market, but the deal may not get done as analysts speculate that competitors Stryker and J&J could step in with counteroffers. But the interest surrounding Austin, TX-based ArthroCare emphasizes the pressures being put on large joint makers to find new ways of making money in orthopedics.
Stryker Aims To Be Greater Than The Sum Of Its Parts
Stryker says it is shifting from “fierce decentralization” to more collaboration between business units to offer customers more holistic solutions.